David M. Knott Jr’s Syndax Pharmaceuticals SNDX Stock Holding History

David M. Knott Jr’s Portfolio SNDX Stock Details SNDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.86M	Buy	422,000 +7,000	+2%	+$152K	5.87%	3
2025 Q4	$8.72M	Sell	415,000 -13,000	-3%	-$227K	4.04%	4
2025 Q3	$6.58M	Buy	428,000 +75,222	+21%	+$985K	2.76%	7
2025 Q2	$3.3M	Buy	352,778 +224,778	+176%	+$2.47M	1.5%	14
2025 Q1	$1.57M	Hold	128,000	–	–	0.74%	22
2024 Q4	$1.69M	Buy	128,000 +5,856	+5%	+$100K	0.61%	24
2024 Q3	$2.35M	Buy	122,144 +18,318	+18%	+$378K	0.83%	30
2024 Q2	$2.13M	Buy	103,826 +38,351	+59%	+$803K	0.85%	26
2024 Q1	$1.56M	Buy	+65,475	New	+$1.46M	0.55%	33

Other funds holding SNDX

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return

Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return